AUTL vs GNRC · rev $71.9M vs P/E 82, rev $1.17B
Autolus Therapeutics Ltd (AUTL) versus Generac Holdings Inc (GNRC) — a side-by-side from cached financials, not a winner call.
Autolus Therapeutics Ltd (AUTL) is a biotechnology company listed on US.
Generac Holdings Inc (GNRC) is a specialty industrial machinery company listed on US.
Latest reported AUTL revenue for 2026-06-30 was $71.9M. Net income was -$110.7M. AUTL currently screens at market cap $614.8M.
Latest reported GNRC revenue for 2026-06-30 was $1.17B. Net income was $143.2M. Revenue was up 10.8% from 2026-03-31 to 2026-06-30. GNRC currently screens at market cap $15.40B and trailing P/E 82.0.
AUTL currently screens at market cap $614.8M. GNRC currently screens at market cap $15.40B and trailing P/E 82.0.
Not investment advice. Open the AUTL and GNRC stock pages for the full models.
Not investment advice.